[Company Performance]: JNJ's financial health, including revenue, profit margins, and earnings per share (EPS), directly influences investor confidence and stock value.

[Pharmaceutical Pipeline]: The success and progress of Johnson & Johnson's drug development pipeline significantly impact future revenue expectations and stock price.

[Medical Device Sales]: Performance of the medical device segment, affected by innovation, competition, and healthcare spending trends, plays a crucial role.

[Consumer Health Products]: Sales and market share of J&J's consumer health products influence overall revenue and brand perception, impacting the stock.

[Regulatory Approvals]: FDA and other regulatory body decisions on drug approvals and product clearances have a major effect on stock price.

[Patent Protection]: The strength and duration of J&J's patent portfolio are vital for maintaining market exclusivity and future profitability.

[Litigation and Legal Issues]: Lawsuits, especially those related to product safety or marketing practices, can negatively affect stock value.

[Overall Market Conditions]: Broad economic trends, interest rates, and investor sentiment impact the entire stock market, including JNJ.MX.

[Industry Trends]: Shifts in the healthcare industry, such as the rise of biosimilars or changes in healthcare policies, influence J&J's business and stock price.

[Competition]: Actions of competitors, including new product launches or pricing strategies, affect J&J's market position and stock performance.

[Dividend Policy]: J&J's dividend payments and dividend yield are attractive to investors and can support the stock price.

[Mergers and Acquisitions]: Any significant M&A activity by J&J or its competitors can influence investor perception and stock valuation.

[Global Economic Factors]: Economic conditions in key markets around the world impact J&J's international sales and earnings, affecting the stock.

[Currency Exchange Rates]: Fluctuations in currency exchange rates can impact the value of J&J's international earnings when translated back to the reporting currency.